Journal of the American Society of Hypertension
Volume 1, Issue 4 , Pages 264-277, July 2007

Antihypertensive efficacy, safety, and tolerability of the oral direct renin inhibitor aliskiren in patients with hypertension: a pooled analysis

  • Matthew R. Weir, MD

      Affiliations

    • Division of Nephrology, University of Maryland School of Medicine, Baltimore, Maryland, USA
    • Dr. Matthew R. Weir has acted as an ad hoc consultant and participated in a speakers’ bureau for Novartis Pharmaceuticals Corporation.
    • Corresponding Author InformationCorresponding author: Matthew R. Weir, MD, Professor and Director, Division of Nephrology, University of Maryland School of Medicine, 22 South Greene Street, Room N3W143, Baltimore, Maryland 21201. Tel: 410-328-5720; fax: 410-328-5685.
  • ,
  • Christopher Bush, PhD

      Affiliations

    • Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA
    • Drs. Christopher Bush, David R. Anderson, Jack Zhang, Deborah Keefe, and Andrew Satlin are employees of Novartis Pharmaceuticals Corporation and as such are eligible for Novartis stock and stock options.
  • ,
  • David R. Anderson, MD

      Affiliations

    • Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA
    • Drs. Christopher Bush, David R. Anderson, Jack Zhang, Deborah Keefe, and Andrew Satlin are employees of Novartis Pharmaceuticals Corporation and as such are eligible for Novartis stock and stock options.
  • ,
  • Jack Zhang, MD, PhD

      Affiliations

    • Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA
    • Drs. Christopher Bush, David R. Anderson, Jack Zhang, Deborah Keefe, and Andrew Satlin are employees of Novartis Pharmaceuticals Corporation and as such are eligible for Novartis stock and stock options.
  • ,
  • Deborah Keefe, MD

      Affiliations

    • Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA
    • Drs. Christopher Bush, David R. Anderson, Jack Zhang, Deborah Keefe, and Andrew Satlin are employees of Novartis Pharmaceuticals Corporation and as such are eligible for Novartis stock and stock options.
  • ,
  • Andrew Satlin, MD

      Affiliations

    • Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA
    • Drs. Christopher Bush, David R. Anderson, Jack Zhang, Deborah Keefe, and Andrew Satlin are employees of Novartis Pharmaceuticals Corporation and as such are eligible for Novartis stock and stock options.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This study was funded by Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.

PII: S1933-1711(07)00089-7

doi:10.1016/j.jash.2007.04.004

Journal of the American Society of Hypertension
Volume 1, Issue 4 , Pages 264-277, July 2007